TCI Wealth Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

TCI Wealth Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$75	–	2475
2023 Q1	$75	Hold	100	–	–	﹤0.01%	2418
2022 Q4	$37	Buy	+100	New	+$42	﹤0.01%	2446
2021 Q3	–	Sell	-571	Closed	-$2K	–	2637
2021 Q2	$2K	Buy	+571	New	+$1.98K	﹤0.01%	2140
2020 Q1	–	Sell	-247	Closed	-$1K	–	1827
2019 Q4	$1K	Hold	247	–	–	﹤0.01%	1478
2019 Q3	$2K	Hold	247	–	–	﹤0.01%	1183
2019 Q2	$2K	Hold	247	–	–	﹤0.01%	1099
2019 Q1	$3K	Hold	247	–	–	﹤0.01%	964
2018 Q4	$2K	Hold	247	–	–	﹤0.01%	1089
2018 Q3	$4K	Hold	247	–	–	﹤0.01%	873
2018 Q2	$5K	Hold	247	–	–	﹤0.01%	797
2018 Q1	$4K	Hold	247	–	–	﹤0.01%	809
2017 Q4	$5K	Hold	247	–	–	﹤0.01%	804
2017 Q3	$3K	Hold	247	–	–	﹤0.01%	890
2017 Q2	$2K	Hold	247	–	–	﹤0.01%	1045
2017 Q1	$2K	Hold	247	–	–	﹤0.01%	996
2016 Q4	$1K	Buy	+247	New	+$1.04K	﹤0.01%	1269
2016 Q3	–	Sell	-69	Closed	–	–	1419
2016 Q2	$0	Buy	+69	New	+$488	﹤0.01%	1401

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCI Wealth Advisors's SPPI Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 100 shares — an estimated $75 sold.

TCI Wealth Advisors first reported a position in SPPI in Q2 2016 and held it in 17 quarters. The position peaked at $5K in Q2 2018. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

TCI Wealth Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 100 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $75.
TCI Wealth Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 17 quarters.
TCI Wealth Advisors's Spectrum Pharmaceuticals Inc position peaked at $5K in Q2 2018.
78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.